These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 18388529

  • 1. Vasculitis in Behçet's syndrome: evidence-based review.
    Reynolds N.
    Curr Opin Rheumatol; 2008 May; 20(3):347-52. PubMed ID: 18388529
    [No Abstract] [Full Text] [Related]

  • 2. Potassium iodide in the treatment of erythema nodosum and nodular vasculitis.
    Horio T, Imamura S, Danno K, Ofuji S.
    Arch Dermatol; 1981 Jan; 117(1):29-31. PubMed ID: 7458376
    [Abstract] [Full Text] [Related]

  • 3. Radial artery occlusion, a rare presentation of Behçet's disease.
    Gera C, Jose W, Malhotra N, Malhotra V, Dhanoa J.
    J Assoc Physicians India; 2008 Aug; 56():643-4. PubMed ID: 19051714
    [Abstract] [Full Text] [Related]

  • 4. Necrotizing vasculitis--a 2009 update.
    Sharaf PH, Yazici Y.
    Bull NYU Hosp Jt Dis; 2009 Aug; 67(3):303-5. PubMed ID: 19852754
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pustular vasculitis disclosing Behçet disease].
    Castanet J, Carmignani S, Lacour JP, Perrin C, Lagrange B, Dor JF, Ortonne JP.
    Ann Dermatol Venereol; 1994 Aug; 121(9):629-31. PubMed ID: 7771731
    [Abstract] [Full Text] [Related]

  • 7. Erythema nodosum-like lesions in Behçet's disease: a clinicopathological study of 26 cases.
    Misago N, Tada Y, Koarada S, Narisawa Y.
    Acta Derm Venereol; 2012 Nov; 92(6):681-6. PubMed ID: 22504656
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Erythema nodosum-like lesions in Behçet's syndrome: a histopathologic study of 30 cases.
    Chun SI, Su WP, Lee S, Rogers RS.
    J Cutan Pathol; 1989 Oct; 16(5):259-65. PubMed ID: 2592624
    [Abstract] [Full Text] [Related]

  • 12. Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet's uveitis.
    Onal S, Kazokoglu H, Koç A, Akman M, Bavbek T, Direskeneli H, Yavuz S.
    Clin Exp Rheumatol; 2009 Oct; 27(2 Suppl 53):S113-4. PubMed ID: 19796551
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation criteria for uveitis in Behçet's syndrome].
    Hamza M, Ouertani A.
    Rev Rhum Ed Fr; 1993 Apr; 60(4):315-6. PubMed ID: 8167635
    [No Abstract] [Full Text] [Related]

  • 14. Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.
    Gómez-Puerta JA, Espinosa G, Miró JM, Sued O, Llibre JM, Cervera R, Font J.
    Isr Med Assoc J; 2006 Jul; 8(7):513-4. PubMed ID: 16889175
    [No Abstract] [Full Text] [Related]

  • 15. [Pars planitis and Behçet's syndrome].
    Ardouin M, Urvoy M, Perraut JP.
    Bull Soc Ophtalmol Fr; 1978 Dec; 78(12):931-3. PubMed ID: 755579
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.
    Olivieri I, Padula A, Leccese P, D'Angelo S, Giasi V.
    J Rheumatol; 2009 Apr; 36(4):855. PubMed ID: 19342728
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.